Context Therapeutics Inc.
CNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001842952
No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Context Therapeutics Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +19 vs. Q3 2021
- Shares held
- 3.55M
- +3.55M vs. Q3 2021
- Total value
- $9.44M
- +$9.44M vs. Q3 2021
- New holders
- 19
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $34.8M |
| Q1 2026 | 60 | $194.6M |
| Q4 2025 | 43 | $96.0M |
| Q3 2025 | 37 | $66.8M |
| Q2 2025 | 39 | $45.0M |
| Q1 2025 | 42 | $43.7M |
| Q4 2024 | 52 | $76.4M |
| Q3 2024 | 42 | $111.2M |
| Q2 2024 | 34 | $114.3M |
| Q1 2024 | 25 | $5.43M |
| Q4 2023 | 24 | $4.02M |
| Q3 2023 | 23 | $3.89M |
| Q2 2023 | 22 | $3.58M |
| Q1 2023 | 22 | $722.6K |
| Q4 2022 | 24 | $2.55M |
| Q3 2022 | 24 | $4.59M |
| Q2 2022 | 20 | $6.32M |
| Q1 2022 | 16 | $6.30M |
| Q4 2021 | 19 | $9.44M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Context Therapeutics Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 1,230,830 | $3.27M | 0.82% | +1,230,830 | New |
| AIGH Capital Management LLC | 762,721 | $2.03M | 0.63% | +762,721 | New |
| Altium Capital Management LP | 493,531 | $1.31M | 0.37% | +493,531 | New |
| Empery Asset Management, LP | 358,617 | $954.0K | 1.99% | +358,617 | New |
| Vanguard Group Inc | 214,679 | $571.0K | 0.00% | +214,679 | New |
| Worth Venture Partners, LLC | 174,967 | $465.0K | 0.23% | +174,967 | New |
| Veritable, L.P. | 110,249 | $293.0K | 0.00% | +110,249 | New |
| Renaissance Technologies LLC | 64,618 | $172.0K | 0.00% | +64,618 | New |
| Virtu Financial LLC | 53,521 | $142.0K | 0.01% | +53,521 | New |
| swisspartners Ltd. | 42,235 | $114.0K | 0.08% | +42,235 | New |
| QCM Cayman, Ltd. | 14,041 | $37.0K | 0.22% | +14,041 | New |
| BlackRock Inc. | 11,547 | $31.0K | 0.00% | +11,547 | New |
| HRT Financial LP | 10,160 | $27.0K | 0.00% | +10,160 | New |
| Morgan Stanley | 5,000 | $13.0K | 0.00% | +5,000 | New |
| Tower Research Capital LLC (TRC) | 2,054 | $6.00K | 0.00% | +2,054 | New |
| Amplius Wealth Advisors, LLC | 600 | $1.00K | 0.00% | +600 | New |
| Wells Fargo & Company | 33 | $0 | 0.00% | +33 | New |
| Royal Bank of Canada | 100 | $0 | 0.00% | +100 | New |
| Retirement Group, LLC | 155 | $0 | 0.00% | +155 | New |